RZLT
Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.84
−2.78%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-27.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Karnawat Sunil Ratilal · officer: Chief Commercial Officer | F-InKind | 2,267 | $4.50 |
| Jul 7, 2026 | ROBERTS BRIAN KENNETH · officer: Chief Medical Officer | F-InKind | 3,062 | $4.99 |
| Jul 7, 2026 | Elam Nevan C · director, officer: CEO | F-InKind | 8,004 | $4.99 |
| Jul 7, 2026 | Evans Daron · officer: CFO | F-InKind | 3,062 | $4.99 |
| Mar 31, 2026 | Evans Daron · officer: CFO | Purchase | 10,000 | $2.85 |
| Mar 4, 2026 | Evans Daron · officer: CFO | F-InKind | 11,438 | $2.99 |
| Mar 4, 2026 | ROBERTS BRIAN KENNETH · officer: Chief Medical Officer | F-InKind | 11,439 | $2.99 |
| Mar 4, 2026 | Elam Nevan C · director, officer: CEO | F-InKind | 27,618 | $2.99 |
| Dec 17, 2025 | ROBERTS BRIAN KENNETH · officer: Chief Medical Officer | Purchase | 28,000 | $1.70 |
| Dec 17, 2025 | Hogenhuis Wladimir · director | Purchase | 5,650 | $1.69 |
| Dec 15, 2025 | Karnawat Sunil Ratilal · officer: Chief Commercial Officer | Purchase | 12,000 | $1.62 |
| Dec 15, 2025 | Karnawat Sunil Ratilal · officer: Chief Commercial Officer | Purchase | 100 | $1.60 |
| Dec 15, 2025 | Elam Nevan C · director, officer: CEO | Purchase | 32,000 | $1.59 |
| Dec 15, 2025 | Evans Daron · officer: CFO | Purchase | 40,000 | $1.77 |
| Dec 15, 2025 | Evans Daron · officer: CFO | Purchase | 2,500 | $1.79 |
| Nov 21, 2025 | KREHER NERISSA · director | A-Award | 12,000 | $10 |
| Nov 21, 2025 | Hogenhuis Wladimir · director | A-Award | 21,000 | $0.00 |
| Nov 21, 2025 | Hogenhuis Wladimir · director | A-Award | 12,000 | $10 |
| Nov 21, 2025 | Harris Erik · director | A-Award | 21,000 | $0.00 |
| Nov 21, 2025 | Harris Erik · director | A-Award | 12,000 | $10 |
| Nov 21, 2025 | Kim Young-Jin · director | A-Award | 21,000 | $0.00 |
| Nov 21, 2025 | Kim Young-Jin · director | A-Award | 12,000 | $10 |
| Nov 21, 2025 | FAUCHET PHILIPPE · director | A-Award | 21,000 | $0.00 |
| Nov 21, 2025 | FAUCHET PHILIPPE · director | A-Award | 12,000 | $10 |
| Nov 21, 2025 | Labrucherie Gil M · director | A-Award | 21,000 | $0.00 |
| Nov 21, 2025 | Labrucherie Gil M · director | A-Award | 12,000 | $10 |
| Nov 21, 2025 | Elam Nevan C · director, officer: CEO | A-Award | 317,000 | $0.00 |
| Nov 21, 2025 | Elam Nevan C · director, officer: CEO | A-Award | 186,000 | $10 |
| Nov 21, 2025 | Evans Daron · officer: CFO | A-Award | 107,000 | $0.00 |
| Nov 21, 2025 | KREHER NERISSA · director | A-Award | 21,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 74Increased 97Reduced 73Sold out 19
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FEDERATED HERMES, INC. | Reduced | 12,990,659 | May 11, 2026 |
| FEDERATED HERMES, INC. | Unchanged | 12,990,659 | Aug 12, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 9,445,039 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 9,180,000 | May 15, 2026 |
| BlackRock, Inc. | Increased | 7,718,291 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 6,313,503 | May 13, 2026 |
| OPALEYE MANAGEMENT INC. | Reduced | 6,300,000 | May 15, 2026 |
| Opaleye Management Inc. | Unchanged | 6,300,000 | Aug 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 5,048,421 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Reduced | 4,662,039 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,835,827 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,522,080 | May 15, 2026 |
| JENNISON ASSOCIATES LLC | New Position | 3,438,881 | May 6, 2026 |
| Siren, L.L.C. | Unchanged | 3,328,287 | Aug 13, 2026 |
| SIREN, L.L.C. | New Position | 3,328,287 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026